Back to Agenda
MARKET ACCESS/PRICING
Session Chair(s)
Christian Schneider, DrMed
Head of Biopharma Excellence and Chief Medical Officer (Biopharma)
PharmaLex, Denmark
Speaker(s)
Biosimilars versus Generics: From regulation to market
Fernando De Mora
Universitat Autonoma de Barcelona, Spain
Professor
Per Troein, MBA, MSc
IQVIA, United Kingdom
VP Strategic Partners
Role of HTA for Biosimilars
Jorge Mestre-Ferrandiz, PhD
Office of Health Economics, United Kingdom
Director of Consulting
Have an account?